Mitsui Chemicals, Inc. (Tokyo: 4183; President & CEO: HASHIMOTO Osamu) and Jiksak Bioengineering Inc. (Saiwai-ku, Kawasaki; CEO: KAWADA Jiro) have
On December 10, 2021, Jiksak Bioengineering was honored to present the company’s technology at a webinar hosted by Elixirgen Scientific, Inc, entitled
Jiksak has been selected to participate in Tokyo City’s 2021 Advanced Medical Devices Acceleration Program (AMDAP). The program, which aims to support
KAWASAKI, Japan - August 17, 2021 - Jiksak Bioengineering, Inc. (Jiksak) and Meiji Co., Ltd. (Meiji) today announced that they entered into a j
Joint research between Tohoku University and Keio University School of Medicine used Jiksak Bioengineering, Inc (Jiksak)’s Nerve Organoid™ chips and i
KAWASAKI, Japan – March 30, 2021 – Jiksak Bioengineering, Inc. (Jiksak), a biotechnology company focused on finding a cure for amyotrophic lateral scl
